United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Pharma Industry News QIAGEN files lawsuit against bioMérieux to defend QuantiFERON patents and innovation in TB diagnostics QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has initiated legal proceedings against bioMérieux S.A. (EPA: BIM) in… byPallavi MadhirajuMarch 3, 2025